Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Aveo crawled time : 23:00 save search
AVEO Oncology to Present Positive New Long-Term PFS Data from Phase 3 TIVO-3 Study of FOTIVDA® (tivozanib) in Third- and Fourth-Line Renal Cell Carcinoma
Published: 2022-02-14 (Crawled : 23:00) - globenewswire.com
AVEO | $15.0 0.0% 0
|
Health Technology
|
| O: 0.86%
H: 3.97%
C: 3.97%
fotivda renal cel positive phase 3 cell carcinoma
AVEO Oncology Announces Clinical Trial Collaboration and Supply Agreement with Merck KGaA, Darmstadt, Germany to Evaluate Ficlatuzumab and ERBITUX® (cetuximab) in Patients with Recurrent or Metastatic HNSCC
Published: 2022-01-04 (Crawled : 23:00) - biospace.com/
AVEO | $15.0 0.0% 0
|
Health Technology
|
| O: -1.33%
H: 0.0%
C: 0.0%
erbitux trial germany collaboration
(Senior) Medical Science Liaison
Published: 2021-10-04 (Crawled : 23:00) - aveooncology.com
AVEO | $15.0 0.0% 0
|
Health Technology
|
| O: 0.16%
H: 1.62%
C: -1.14%
The (Senior) Medical Science Liaison
Published: 2021-10-04 (Crawled : 23:00) - aveooncology.com
AVEO | $15.0 0.0% 0
|
Health Technology
|
| O: 0.16%
H: 1.62%
C: -1.14%
The Medical Science Liaison
Published: 2021-10-04 (Crawled : 23:00) - aveooncology.com
AVEO | $15.0 0.0% 0
|
Health Technology
|
| O: 0.16%
H: 1.62%
C: -1.14%
Associate Director/Director, Biologics Development and Manufacturing
Published: 2021-10-04 (Crawled : 23:00) - aveooncology.com
AVEO | $15.0 0.0% 0
|
Health Technology
|
| O: 0.16%
H: 1.62%
C: -1.14%
Director of Scientific Communications and Training
Published: 2021-10-04 (Crawled : 23:00) - aveooncology.com
AVEO | $15.0 0.0% 0
|
Health Technology
|
| O: 0.16%
H: 1.62%
C: -1.14%
communication communications train
Medical Science Liaison
Published: 2021-10-04 (Crawled : 23:00) - aveooncology.com
AVEO | $15.0 0.0% 0
|
Health Technology
|
| O: 0.16%
H: 1.62%
C: -1.14%
Associate/Director Regulatory CMC
Published: 2021-10-04 (Crawled : 23:00) - aveooncology.com
AVEO | $15.0 0.0% 0
|
Health Technology
|
| O: 0.16%
H: 1.62%
C: -1.14%
Director, Strategic Pricing & Contracting
Published: 2021-10-04 (Crawled : 23:00) - aveooncology.com
AVEO | $15.0 0.0% 0
|
Health Technology
|
| O: 0.16%
H: 1.62%
C: -1.14%
contract
Director, Strategic Pricing & Contracting
Published: 2021-08-25 (Crawled : 23:00) - aveooncology.com
AVEO | $15.0 0.0% 0
|
Health Technology
|
| O: -0.16%
H: 1.62%
C: -0.32%
contract
AVEO Announces Appointment of Mike Ferraresso to Chief Commercial Officer
Published: 2021-03-10 (Crawled : 23:00) - investor.aveooncology.com
AVEO | $15.0 0.0% 0
|
Health Technology
|
| O: 16.49%
H: 2.47%
C: -33.31%
commercialization
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.